Pancreatic Enzyme Replacement Therapy, Pancreatic Exocrine Insufficiency, Pancreaticoduodenectomy
Conditions
Brief summary
A comprehensive perioperative nutrition management plan for pancreaticoduodenectomy, primarily based on pancreatic enzyme replacement therapy (PERT). A prospective randomized controlled study was conducted to comprehensively analyze the perioperative nutritional status of patients undergoing pancreaticoduodenectomy, with the aim of exploring: 1. The effect of PERT on postoperative complications and physiological status after pancreaticoduodenectomy; 2. The efficacy of PERT treatment on clinical symptoms, nutritional indicators, and quality of life (QOL) related to pancreatic exocrine dysfunction (PEI) after pancreaticoduodenectomy; 3. The personalized full process nutrition management strategies based on risk factor stratification.
Interventions
pancreatic enzyme replacement therapy
Routine treatment plan without PERT
Sponsors
Study design
Eligibility
Inclusion criteria
* Gender unlimited, 18-80 years old; * Patients undergoing pancreaticoduodenectomy due to various benign or malignant diseases; * Voluntary testing with informed consent.
Exclusion criteria
* Pregnant women and lactating women * Patients with distant metastasis based on tumor staging before surgery; * Tumor recurrence; * Refuse to sign the consent form.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Abdominal Skeletal Muscle Index (SMI) | 8 weeks post-operation | Measurement of abdominal skeletal muscle area at the third lumbar spine plane using abdominal plain scan CT and comparison of baseline level SMI change rate. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative complications | 8 weeks post-operation | postoperative pancreatic fistula, delayed gastric emptying, postoperative hypoproteinemia; |
| Nutritional indicators | 8 weeks post-operation | Patient generated subjective global assessment (PG-SGA); |
Countries
China